-
1
المؤلفون: Paul Welsh, Ashita Waterston, Augusto C. Montezano, Francisco J. Rios, Jeff White, Karla B Neves, Rhian M. Touyz, Patrick B. Mark, Kelly R. McMahon, Alan C. Cameron, Mark Hall, Ninian N. Lang
المصدر: Jacc. Cardiooncology
JACC. CardioOncology, Vol 2, Iss 3, Pp 443-455 (2020)
JACC: CardioOncologyمصطلحات موضوعية: Oncology, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, medicine.medical_treatment, cisplatin, BEP, bleomycin, etoposide and cisplatin, vWF, von Willebrand factor, atherosclerosis, cancer, chemotherapy, Bleomycin, lcsh:RC254-282, endothelial dysfunction, Nephrotoxicity, ICAM, intracellular adhesion molecule, chemistry.chemical_compound, Internal medicine, platinum therapy, medicine, 0FMD, flow-mediated dilatation, Endothelial dysfunction, germ cell tumors, t-PA, tissue plasminogen activator, Testicular cancer, Etoposide, thrombosis, Original Research, Cisplatin, Chemotherapy, business.industry, ACh, acetylcholine, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, testicular cancer, chemistry, lcsh:RC666-701, Cohort, SNP, sodium nitroprusside, PAI, plasminogen activator inhibitor, vasoreactivity, FBF, forearm blood flow, Cardiology and Cardiovascular Medicine, business, BK, bradykinin, Editorial Comment, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7b0e33ae5e1978d0b80127f30701a6Test
http://europepmc.org/articles/PMC7539369Test -
2
المؤلفون: Christoph Hoeller, Marie-Francoise Avril, Pietro Quaglino, François Aubin, Lars Bastholt, Takashi Inozume, Virginia Ferraresi, Michael B. Jameson, Kevin B. Kim, Oliver Bechter, Dirk Schadendorf, Kenji Yokota, Carmen Loquai, Maria-Jose Passos, Inge Marie Svane, Michele Maio, Catherine Barrow, Frank Meiss, Nageatte Ibrahim, Andrzej Mackiewicz, Phillip Parente, Tatsuya Takenouchi, Caroline Dutriaux, Piotr Rutkowski, Alfonsus J M van den Eertwegh, Paola Queirolo, Catriona M. McNeil, Peter Mohr, Felix Kiecker, Susana Puig, Friedegund Meier, Lutz Kretschmer, Alexander C.J. van Akkooi, Alex Menzies, Timothy Crook, Christian U. Blank, Suzana Matkovic, Michael C. Brown, Ragini R. Kudchadkar, Max Levin, Rüdiger Hein, Tanja Skytta, Gerald P. Linette, Clemens Krepler, Adnan Khattak, Ernest Marshall, Joseph Kerger, Oddbjorn Straume, Laurent Mortier, Jochen Utikal, Micaela Hernberg, James Larkin, Yoshio Kiyohara, Mario Mandalà, Henrik Schmidt, Daniil Stroyakovskiy, Pablo Luis Ortiz Romero, Naoya Yamazaki, John Walker, Anna Maria Di Giacomo, Lionel Geoffrois, Jean-Philippe Lacour, Caroline Robert, Vincent Descamps, Shahneen Sandhu, Gil Bar-Sela, Paul C. Nathan, Marcin Dzienis, Ralf Gutzmer, Claus Garbe, Andrey Meshcheryakov, Patrick Combemale, Martin Fehr, Guzel Mukhametshina, Helena Kapiteijn, Geke A. P. Hospers, Jun Aoi, Andrew Haydon, Rutger H. T. Koornstra, Marie-Thérèse Leccia, Sigrun Hallmeyer, Pier Francesco Ferrucci, Jean-Jacques Grob, Leonel Hernandez-Aya, Jan-Christoph Simon, Vanna Chiarion Sileni, Alain Algazi, Lidija Sekulovic, Sandrine Marreaud, Bernard Fitzharris, Jacob Schachter, Xinni Song, Wolf-Henning Boehncke, Rahima Jamal, Paul Lorigan, Maureen J.B. Aarts, Reinhard Dummer, Mike McCrystal, César Martins, Reiner Hofmann-Wellenhof, Alexander M.M. Eggermont, Carola Berking, Elaine Dunwoodie, Bernard Guillot, Michal Kicinski, Philippe Saiag, Céleste Lebbé, Thierry Lesimple, Stefan Suciu, Michal Lotem, Paula Ferreira, Mohammed M. Milhem, Laurent Machet, Patrick Terheyden, Anna Katharina Winge-Main, Peter Hersey, Jean-Francois Baurain, Axel Hauschild, Stéphane Dalle, Jean-Philippe Arnault, Paolo A. Ascierto, Gerard Groenewegen, Florent Grange, Georgina V. Long, Victoria Atkinson, Philippa Corrie, Matteo S. Carlino, Thomas Jouary, Daniel Hendler, Richard Casasola, Ashita Waterston, Jessica C. Hassel
المساهمون: University Medical Center [Utrecht], Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy], The University of Sydney, Princess Alexandra Hospital, Brisbane, University of Queensland [Brisbane], Centre Léon Bérard [Lyon], Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), N.N. Blokhin National Medical Research Center of Oncology, Edith Cowan University (ECU), Royal Marsden NHS Foundation Trust, Universitat de Barcelona (UB), Instituto de Salud Carlos III [Madrid] (ISC), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Universitätsklinikum Essen [Universität Duisburg-Essen] (Uniklinik Essen), Radboud University Medical Center [Nijmegen], Washington University School of Medicine in St. Louis, Washington University in Saint Louis (WUSTL), University Hospital of Siena, Amsterdam UMC - Amsterdam University Medical Center, Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hannover Medical School [Hannover] (MHH), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), The Christie NHS Foundation Trust [Manchester, Royaume-Uni], Merck & Co. Inc, European Organisation for Research and Treatment of Cancer [Bruxelles] (EORTC), European Cancer Organisation [Bruxelles] (ECCO), Institut Gustave Roussy (IGR), Oncologie dermatologique, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Internal medicine, CCA - Cancer Treatment and quality of life
المصدر: EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 643-654 . https://doi.org/10.1016/S1470-2045Test(21)00065-6
Lancet Oncology, 22, 643-654
Lancet Oncology, 22, 5, pp. 643-654
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.643-654. ⟨10.1016/S1470-2045(21)00065-6⟩
The Lancet Oncology, 22(5), 643-654. Lancet Publishing Groupمصطلحات موضوعية: Male, Skin Neoplasms, Medizin, Pembrolizumab, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], MESH: Aged, 80 and over, 0302 clinical medicine, Randomized controlled trial, law, Monoclonal, 80 and over, MESH: Double-Blind Method, 030212 general & internal medicine, Neoplasm Metastasis, Humanized, Melanoma, MESH: Aged, Aged, 80 and over, education.field_of_study, MESH: Middle Aged, Hazard ratio, MESH: Neoplasm Staging, Middle Aged, Oncology, 030220 oncology & carcinogenesis, Female, Adult, Aged, Antibodies, Monoclonal, Humanized, Double-Blind Method, Humans, Neoplasm Staging, medicine.medical_specialty, MESH: Melanoma, Population, [SDV.CAN]Life Sciences [q-bio]/Cancer, Placebo, Antibodies, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, Adjuvant therapy, education, Cancer staging, MESH: Humans, business.industry, MESH: Skin Neoplasms, MESH: Adult, MESH: Neoplasm Metastasis, MESH: Male, Clinical trial, MESH: Antibodies, Monoclonal, Humanized, business, MESH: Female
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca46af8de45fdf5ffd9d70f717e94208Test
https://research.vumc.nl/en/publications/8aae177c-dfa8-4325-b8c2-e7b1d7339027Test -
3
المؤلفون: Graham MacDonald, Jeff White, David Irvine, Yun Yi Tan, Grant McQuaker, Bahaa Al-Bubseeree, Ashita Waterston, Anne Parker
المصدر: Clinical Genitourinary Cancer. 17:125-131
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Urology, medicine.medical_treatment, 030232 urology & nephrology, Disease, Transplantation, Autologous, Tertiary Care Centers, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Refractory, Ototoxicity, Internal medicine, medicine, Humans, Neoplasm Metastasis, Retrospective Studies, Salvage Therapy, Chemotherapy, business.industry, Medical record, Hematopoietic Stem Cell Transplantation, Cancer, Neoplasms, Germ Cell and Embryonal, medicine.disease, Survival Analysis, Transplantation, Treatment Outcome, Germ cell cancer, Scotland, 030220 oncology & carcinogenesis, Feasibility Studies, Female, Neoplasm Recurrence, Local, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1106fd0f98e065067049da00d7c765Test
https://doi.org/10.1016/j.clgc.2018.11.013Test -
4
المؤلفون: Vanna Chiarion-Sileni, Tina C. Young, Martin Kaatz, Ruth Plummer, Christoph Hoeller, Tormod Kyrre Guren, Michele Maio, Paolo A. Ascierto, Elena Grigoryeva, Paul C. Nathan, Piotr Rutkowski, Dimitrios Bafaloukos, Helen Gogas, Maria Teresa Fierro, Reinhard Dummer, Ashita Waterston, Ivan Marquez-Rodas, Lev V. Demidov, Mario Mandalà, Patrick Terheyden, Ralf Gutzmer, Claus Garbe, Michele Guida, John B. A. G. Haanen, Enrique Espinosa, Dirk Schadendorf, Paul Lorigan, Eva Muñoz-Couselo
المساهمون: University of Zurich, Nathan, Paul
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Medizin, Phases of clinical research, Kaplan-Meier Estimate, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, 1306 Cancer Research, Melanoma, Aged, 80 and over, Mucosal, Incidence (epidemiology), Mucosal melanoma, 10177 Dermatology Clinic, Middle Aged, Advanced melanoma, Acral, Ipilimumab, Nivolumab, Ocular, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, 2730 Oncology, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Adolescent, Ocular Melanoma, 610 Medicine & health, Skin Diseases, Drug Administration Schedule, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, neoplasms, Aged, business.industry, medicine.disease, 030104 developmental biology, Cutaneous melanoma, business
وصف الملف: 808_Nathan_P._et_al._Safety_and_efficacy_of_nivolumab_in_patients_with_rare_melanoma_subtypes_who_progressed_on_or_after_ipilimumab_treamtent_EJC_2019.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50fea214c572dced501f2350795c8ee0Test
https://www.zora.uzh.ch/id/eprint/174048Test/ -
5
المؤلفون: Ashita Waterston, Stephen T. McSorley, Stephan Dreyer, Donald C. McMillan, James J. Going, Joanne Edwards, Paul G. Horgan, Arfon Powell
المصدر: Annals of Surgical Oncology
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Colorectal cancer, Neutrophils, medicine.medical_treatment, Adenocarcinoma, Gastroenterology, 03 medical and health sciences, Hemoglobins, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, Lymphocyte Count, Lymphocytes, Survival rate, Neoadjuvant therapy, Serum Albumin, Aged, Neoplasm Staging, Colorectal Cancer, Aged, 80 and over, Inflammation, business.industry, Platelet Count, Rectal Neoplasms, Cancer, Odds ratio, Chemoradiotherapy, Adjuvant, Middle Aged, medicine.disease, Prognosis, R1, Total mesorectal excision, Neoadjuvant Therapy, Surgery, Radiation therapy, C-Reactive Protein, Oncology, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, business, Radiology, Chemoradiotherapy
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef0c4887c87ca9b4ec901222835aeabTest
http://europepmc.org/articles/PMC5374176Test -
6
المؤلفون: Enrique Espinosa, Dirk Schadendorf, Christoph Hoeller, Paul C. Nathan, Tormod Kyrre Guren, Paolo A. Ascierto, Reinhard Dummer, Elena Grigoryeva, Tina C. Young, Patrick Terheyden, Ivan Marquez-Rodas, Martin Kaatz, Ralf Gutzmer, Claus Garbe, Mario Mandalà, Ashita Waterston, Ruth Plummer, Michele Maio, Eva Muñoz-Couselo, Vanna Chiarion-Sileni, Dimitrios Bafaloukos, Maria Teresa Fierro, Piotr Rutkowski, Lev V. Demidov, Helen Gogas, John B. A. G. Haanen, Michele Guida, Paul Lorigan
المساهمون: University of Zurich, Schadendorf, Dirk
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Medizin, Phases of clinical research, ECOG Performance Status, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, 1306 Cancer Research, Melanoma, Aged, 80 and over, Incidence (epidemiology), Advanced melanoma, Autoimmune, CNS metastasis, ECOG performance status, Ipilimumab, Nivolumab, 10177 Dermatology Clinic, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, 2730 Oncology, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, 610 Medicine & health, Asymptomatic, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, Adverse effect, Aged, Neoplasm Staging, business.industry, Survival Analysis, Clinical trial, 030104 developmental biology, Drug Resistance, Neoplasm, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48abb2e73d26f6fad8dfcfa853ddfd01Test
http://hdl.handle.net/11365/1083701Test -
7
المؤلفون: Ashita Waterston, Jeff White, Douglas Cartwright
المصدر: Poster abstracts.
مصطلحات موضوعية: Oncology, Vincristine, Chemotherapy, medicine.medical_specialty, Cyclophosphamide, business.industry, medicine.medical_treatment, medicine.disease, Chemotherapy regimen, Regimen, medicine.anatomical_structure, Internal medicine, medicine, Germ cell tumors, business, Etoposide, Germ cell, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::63f35d40c2da5e61206d9550f81a350aTest
https://doi.org/10.1136/postgradmedj-2018-fpm.26Test -
8
المؤلفون: Stephen Houston, Andrea Marshall, Charles Kelly, Neville Davidson, Paul Lorigan, Mark R. Middleton, Martin Gore, Satish Kumar, Mark Harries, Paul Nathan, Sarah Danson, Maria Marples, Ruth E Board, Steve Nicholson, Ernest Marshall, Pippa Corrie, Jenny Nobes, Ashita Waterston, Gemma Young, Janet A. Dunn
المصدر: The Lancet Oncology. 15(6):620-630
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Skin Neoplasms, Adolescent, Bevacizumab, Phases of clinical research, Antineoplastic Agents, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, Disease-Free Survival, law.invention, RC0254, Young Adult, Randomized controlled trial, Risk Factors, law, Internal medicine, medicine, Clinical endpoint, Humans, Adverse effect, Melanoma, Aged, Proportional Hazards Models, Aged, 80 and over, business.industry, Hazard ratio, Middle Aged, Interim analysis, Surgery, Tolerability, Oncology, Chemotherapy, Adjuvant, Female, Neoplasm Recurrence, Local, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53d74344fabc0e3d30b8b3ef430dee3Test
-
9
المؤلفون: Jeff White, Francisco J. Rios, Rhian M. Touyz, Alan C. Cameron, Ashita Waterston, Ninian N. Lang, Mark Hall
المصدر: Journal of Hypertension. 36:e99
مصطلحات موضوعية: Cisplatin, Physiology, business.industry, Internal Medicine, Cancer research, medicine, Cancer, Cardiology and Cardiovascular Medicine, medicine.disease, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::049ec8e83f0439a2968ea9a3273997cbTest
https://doi.org/10.1097/01.hjh.0000539254.11971.d4Test -
10
المؤلفون: Claire Scudder, James Paul, A.S. Dhadda, Niels Henrik Hollander, Richard Ellis, Ashita Waterston, S Falk, Mark Harrison, Kathleen A Boyd, Bengt Glimelius, Andrew Haydon, Sherif Abdel-Raouf, Mark N. K. Saunders, Charles Wilson, T. Iveson, Andrea Harkin, J. Tabernero, Rachel Kerr, Sharadah Essapen, Louise C. Medley
المصدر: Annals of Oncology. 28:v613
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Colorectal cancer, Adjuvant chemotherapy, business.industry, Hematology, medicine.disease, Oxaliplatin, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Non inferiority trial, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cb08deea275310382d9856a876c9ab8eTest
https://doi.org/10.1093/annonc/mdx440.015Test